Anghel LA, Farcas AM, Oprean RN An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019 Apr;92(2):117-122. doi: 10.15386/mpr-1201. Epub 2019 Apr 25. Review.
Asche C, LaFleur J, Conner C A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011 Jan;33(1):74-109. doi: 10.1016/j.clinthera.2011.01.019. Review.
Centers for Disease Control (CDC) National Diabetes Statistics Report 2020. Estimates of diabetes and its burden in the United States. [Internet]. Centers for Disease Control (CDC); 2020 [cited 2022 Jan 10]. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf
Davis F, Davis F Perceived Usefulness, Perceived Ease of Use, and User Acceptance of Information Technology. MIS Quarterly. 1989 Sep 1; 13:319.
de Oliveira-Filho AD, Morisky DE, Neves SJ, Costa FA, de Lyra DP Jr The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults. Res Social Adm Pharm. 2014 May-Jun;10(3):554-61. doi: 10.1016/j.sapharm.2013.10.006. Epub 2013 Oct 26.
Ekpenyong C, Akpan U, Ibu J, Nyebuk D Gender and age specific prevalence and associated risk factors of type 2 diabetes mellitus in Uyo metropolis, South Eastern Nigeria. DiabetologiaCroatica [Internet]. 2012;41(1). Available from: http://www.sciepub.com/reference/340492
Erdogan Ö, Araman A Health beliefs and functional health literacy; Interaction with the pharmaceutical services. Istanbul Journal of Pharmacy. 2017 Oct 18; 47:68-71.
Fasanmade OA, Dagogo-Jack S Diabetes Care in Nigeria. Ann Glob Health. 2015 Nov-Dec;81(6):821-9. doi: 10.1016/j.aogh.2015.12.012. Review.
Free C, Phillips G, Felix L, Galli L, Patel V, Edwards P The effectiveness of M-health technologies for improving health and health services: a systematic review protocol. BMC Res Notes. 2010 Oct 6;3:250. doi: 10.1186/1756-0500-3-250.
Hansen RA, Farley JF, Droege M, Maciejewski ML A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005. Clin Ther. 2010 Jul;32(7):1308-19. doi: 10.1016/j.clinthera.2010.07.011.
Harande Y Exploring the Literature of Diabetes in Nigeria: A Bibliometrics Study. African Journal of Diabetes Medicine. 2011; 2:1-4.
Hong JS, Kang HC Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea. Med Care. 2011 Apr;49(4):378-84. doi: 10.1097/MLR.0b013e31820292d1.
Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT Paying pharmacists for patient care: A systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014 Jul;147(4):209-32. doi: 10.1177/1715163514536678. Review.
Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT Publicly funded remuneration for the administration of injections by pharmacists: An international review. Can Pharm J (Ott). 2013 Nov;146(6):353-64. doi: 10.1177/1715163513506369.
International Diabetes Federation IDF. Clinical practice recommendations for managing type 2 diabetes in primary care. [Internet]. [Cited 2021 Oct 19]. Available from: https://www.idf.org/e-library/guidelines/128-idf-clinical-practice-recommendations-formanaging- type-2-diabetes-in-primary-care.html.
Juarez DT, Tan C, Davis J, Mau M Factors Affecting Sustained Medication Adherence and Its Impact on Health Care Utilization in Patients with Diabetes. J Pharm Health Serv Res. 2013 Jun;4(2):89-94.
Kharroubi AT, Darwish HM Diabetes mellitus: The epidemic of the century. World J Diabetes. 2015 Jun 25;6(6):850-67. doi: 10.4239/wjd.v6.i6.850. Review.
Marciano L, Camerini AL, Schulz PJ The Role of Health Literacy in Diabetes Knowledge, Self-Care, and Glycemic Control: a Meta-analysis. J Gen Intern Med. 2019 Jun;34(6):1007-1017. doi: 10.1007/s11606-019-04832-y. Epub 2019 Mar 15. Review.
Mehas N, Hudmon KS, Jaynes H, Klink S, Downey L, Zillich AJ Impact of Electronic Medication Reminder Caps on Patient Adherence and Blood Pressure. J Pharm Technol. 2021 Oct;37(5):234-243. doi: 10.1177/87551225211018708. Epub 2021 Jul 31.
NB of S (NBS) Nigeria GDP data, Q1, Q2 2021 [Internet]. 17. National Bureau of Statistics (NBS). 2021 [cited 2022 Jan 10]. Available from: https://nigerianstat.gov.ng/elibrary
Ni Z, Liu C, Wu B, Yang Q, Douglas C, Shaw RJ An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention. Int J Nurs Sci. 2018 Sep 8;5(4):322-330. doi: 10.1016/j.ijnss.2018.09.003. eCollection 2018 Oct 10.
Olawuyi AT, Adeoye IA The prevalence and associated factors of non-communicable disease risk factors among civil servants in Ibadan, Nigeria. PLoS One. 2018 Sep 13;13(9):e0203587. doi: 10.1371/journal.pone.0203587. eCollection 2018.
Ramaj A, Kamberi F, Behrens J Effects of Diabetes Education on Emotional Distress in Patients with Type 2 Diabetes-An Experimental Study. Open Journal of Endocrine and Metabolic Diseases. 2019 Feb 19; 9(2):9-20.
World Health Organisation World malaria report 2015. World Health Organisation, Geneva Switzerland; 2016.
World Health Organization Diabetes [Internet]. World Health Organisation, Geneva Switzerland; 2018. Available from: https://www.who.int/news-room/factsheets/ detail/diabetes
World Health Organization Long Term-Therapies: Evidence for Action [Internet]. World Health Organisation, Geneva Switzerland; 2003. Available from: ISBN 92-4-154599-2
Xu L, Li Y, Dai Y, Peng J Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms. Pharmacol Res. 2018 Apr;130:451-465. doi: 10.1016/j.phrs.2018.01.015. Epub 2018 Feb 13. Review.
Evaluation of mHealth Intervention to Improve Medication Adherence in Type 2 Diabetes in Nigeria: a Randomized Controlled Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.